2021 House Bill 5263 / 2022 Public Act 43

Revise certain opioid-related drug prescription procedures

Introduced in the House

Aug. 17, 2021

Introduced by Rep. Mary Whiteford (R-80)

To require health insurers to provide a nonopioid directive form on their website. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.

Referred to the Committee on Health Policy

Nov. 4, 2021

Reported without amendment

With the recommendation that the substitute (H-1) be adopted and that the bill then pass.

Dec. 1, 2021

Passed in the House 96 to 4 (details)

Received in the Senate

Dec. 2, 2021

Referred to the Committee on Health Policy and Human Services

March 8, 2022

Reported without amendment

With the recommendation that the bill pass.

March 10, 2022

Passed in the Senate 38 to 0 (details)

To require health insurers to provide a nonopioid directive form on their website. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.

Signed by Gov. Gretchen Whitmer

March 23, 2022